The prevalence of anti-Helicobacter pylori antibodies in the patients with ischemic heart disease.
The authors proposed to assess the prevalence of anti-Hp antibodies (IgG class) in patients with ischemic heart disease. The study included 93 patients distributed into two groups: a) group A--61 patients with ischemic heart disease; b) group B--32 controls. The Hp infection diagnosis was established by determination of the Hp antibodies in the peripheral blood. Hp infection was correlated with the following factors: (a) smoking, alcohol consumption, antiinflammatory drugs intake and water source; (b) biological parameters (fibrinogen, alpha1-globulins, cholesterol, triglycerides, thrombocyte count). In the patients with ischemic heart disease the prevalence of the Hp infection was 78.3%, and in controls 56.2% (p<0.05). The patients consuming alcohol and smoking had a significantly higher prevalence than controls. Antiinflammatory drugs and water source did not influence the prevalence of the Hp infection. Among the biological parameters, fibrinogen and alpha1 globulins were significantly increased in the Hp-positive patients with ischemic heart disease. In conclusion, the serum prevalence of anti-Hp antibodies was higher in the patients with ischemic heart disease, smokers and alcohol consumers than in health individuals.
Andreica
V
V
3rd Medical Clinic, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. medicala.3@email.ro
Sandica-Andreica
Bianca
B
Draghici
A
A
Chiorean
Erica
E
Georoceanu
Anca
A
Rusu
Margareta
M
D000428:Alcohol Drinking / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000907:Antibodies, Bacterial / Q000097:blood*; D016009:Chi-Square Distribution; D005260:Female; D016481:Helicobacter Infections / Q000097:blood / Q000150:complications*; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000382:microbiology*; D015995:Prevalence; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D014881:Water Supply
D000893:Anti-Inflammatory Agents; D000907:Antibodies, Bacterial